OrbiMed Capital GP VI LLC (CIK 0001682115)

Latest company ownership

VRNA - Verona Pharma plc
Role: Director
Shares held
3,777,778
Last filed at
May 15, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q4 2025Q4
KALA - KALA BIO, Inc.
Role: 10% Owner
Shares held
3,447,840
Last filed at
Feb 12, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4
NPCE - NeuroPace Inc
Role: 10% Owner
Shares held
3,238,199
Last filed at
May 16, 2025
Confidence Score
48.5
2025Q4
Confidence Score History
2021Q2 2025Q4
ACET - Adicet Bio, Inc.
Role: 10% Owner
Shares held
2,930,527
Last filed at
Oct 10, 2025
Confidence Score
87.5
2025Q4
Confidence Score History
2018Q1 2025Q4
IMA - ImageneBio, Inc.
Role: Director
Shares held
2,346,399
Last filed at
Sep 21, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
2,212,571
Last filed at
Mar 31, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
ETNB - 89bio, Inc.
Role: 10% Owner
Shares held
1,829,436
Last filed at
Jan 27, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
CALC - CalciMedica, Inc.
Role: 10% Owner
Shares held
846,574
Last filed at
Sep 29, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
538,646
Last filed at
Dec 3, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
526,300
Last filed at
May 24, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
443,792
Last filed at
Apr 4, 2025
Confidence Score
52.1
2025Q4
Confidence Score History
2021Q1 2025Q4
NXTC - NextCure, Inc.
Role: Director
Shares held
442,438
Last filed at
May 13, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
Shares held
252,858
Last filed at
Aug 15, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4
Shares held
186,541
Last filed at
Mar 26, 2025
Confidence Score
49.4
2025Q4
Confidence Score History
2023Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 8, 2025 Oct 10, 2025 Adicet Bio, Inc. 10% Owner Buy 100.0 +5,000,000 58.71% ✗ $5M
May 14, 2025 May 16, 2025 NeuroPace Inc 10% Owner Sell 17.5 -168,136 -4.94% ✗ $2.7M
Apr 9, 2025 Apr 11, 2025 Compass Therapeutics, Inc. Director Sell 16.3 -3,571,428 -100.00% ✗ $5.7M
Apr 3, 2025 Apr 4, 2025 Edgewise Therapeutics, Inc. Director Buy 95.0 +496,771 3.37% ✗ $10M
Mar 24, 2025 Mar 26, 2025 Disc Medicine, Inc. Director Sell 37.5 -5,738 -0.40% ✗ $310.5K
Mar 19, 2025 Mar 21, 2025 Disc Medicine, Inc. Director Sell 17.5 -52,429 -1.21% ✗ $2.8M
Mar 10, 2025 Mar 12, 2025 Disc Medicine, Inc. Director Sell 15.0 -312,384 -3.87% ✗ $17M
Aug 26, 2024 Aug 28, 2024 ARS Pharmaceuticals, Inc. Director Sell 17.5 -83,695 -100.00% ✗ $1.1M
Aug 21, 2024 Aug 23, 2024 ARS Pharmaceuticals, Inc. Director Sell 15.0 -868,682 -91.21% ✗ $11.5M
Aug 13, 2024 Aug 15, 2024 scPharmaceuticals Inc. 10% Owner Buy 95.0 +500,000 8.99% ✗ $2M
Jun 17, 2024 Jun 20, 2024 Disc Medicine, Inc. Director Buy 92.5 +83,334 4.90% ✗ $3M
May 1, 2024 May 3, 2024 NeuroPace Inc 10% Owner Sell 30.0 -29,206 -0.85% ✗ $409.4K
Apr 24, 2024 Apr 26, 2024 NeuroPace Inc 10% Owner Sell 51.3 -1,781 -0.05% ✗ $25K
Apr 19, 2024 Apr 23, 2024 NeuroPace Inc 10% Owner Sell 20.0 -64,653 -1.85% ✗ $913.1K
Apr 16, 2024 Apr 18, 2024 NeuroPace Inc 10% Owner Sell 40.0 -16,992 -0.48% ✗ $238.2K
Apr 11, 2024 Apr 15, 2024 NeuroPace Inc 10% Owner Sell 16.3 -485,000 -12.11% ✗ $7M
Jan 25, 2024 Jan 26, 2024 Adicet Bio, Inc. Director Buy 100.0 +3,125,000 47.01% ✗ $7.5M
Jan 23, 2024 Jan 25, 2024 Edgewise Therapeutics, Inc. Director Buy 92.5 +454,545 3.25% ✗ $5M
Dec 18, 2023 Dec 20, 2023 Disc Medicine, Inc. Director Sell 47.5 -1,724 -0.10% ✗ $102.1K
Dec 14, 2023 Dec 15, 2023 Disc Medicine, Inc. Director Sell 15.0 -433,200 -20.29% ✗ $24.6M
Dec 12, 2023 Dec 14, 2023 Disc Medicine, Inc. Director Sell 16.3 -134,200 -2.11% ✗ $7.9M
Oct 2, 2023 Oct 4, 2023 NeuroPace Inc 10% Owner Sell 40.0 -8,314 -0.21% ✗ $75.4K
Aug 29, 2023 Aug 31, 2023 ARS Pharmaceuticals, Inc. Director Buy 95.0 +500,000 6.65% ✗ $3.1M
Jun 27, 2023 Jun 29, 2023 Adicet Bio, Inc. Director Buy 100.0 +875,000 12.10% ✗ $1.8M
May 22, 2023 May 24, 2023 Prelude Therapeutics Inc Director Buy 95.0 +869,565 9.40% ✗ $5M
May 11, 2023 May 15, 2023 Verona Pharma plc Director Sell 16.3 -482,913 -11.33% ✗ $9.9M
Feb 15, 2023 Feb 17, 2023 Disc Medicine, Inc. Director Buy 95.0 +108,696 5.03% ✗ $2.5M
Dec 22, 2022 Dec 27, 2022 Verona Pharma plc Director Sell 15.0 -6,139,864 -15.26% ✗ $136M
Nov 25, 2022 Nov 29, 2022 scPharmaceuticals Inc. 10% Owner Buy 100.0 +762,380 16.70% ✗ $4M
Sep 16, 2022 Sep 16, 2022 Edgewise Therapeutics, Inc. Director Buy 92.5 +484,496 3.59% ✗ $5M
Jun 22, 2022 Jun 24, 2022 ImageneBio, Inc. Director Sell 17.5 -252,225 -1.83% ✗ $1.1M
May 18, 2022 May 20, 2022 Edgewise Therapeutics, Inc. Director Buy 85.0 +138,000 1.03% ✗ $995K
Jan 25, 2022 Jan 27, 2022 89bio, Inc. 10% Owner Sell 30.0 -70,573 -0.95% ✗ $592.4K
Apr 21, 2021 Apr 23, 2021 NeuroPace Inc 10% Owner Buy 100.0 +235,000 100.00% ✗ $4M
Mar 30, 2021 Apr 13, 2021 ImageneBio, Inc. Director Buy 100.0 +423,400 27.98% ✗ $6.8M
Mar 30, 2021 Apr 1, 2021 ImageneBio, Inc. Director Buy 100.0 +423,400 22.46% ✗ $6.8M
Mar 30, 2021 Mar 31, 2021 Edgewise Therapeutics, Inc. Director Buy 93.8 +359,375 2.70% ✗ $5.8M
Mar 29, 2021 Mar 31, 2021 Oric Pharmaceuticals, Inc. Director Sell 32.5 -103,424 -4.47% ✓ $2.4M
Mar 24, 2021 Mar 26, 2021 Oric Pharmaceuticals, Inc. Director Sell 32.5 -112,298 -4.62% ✓ $2.8M
Mar 19, 2021 Mar 23, 2021 Oric Pharmaceuticals, Inc. Director Sell 42.5 -32,940 -1.34% ✓ $863.3K
Mar 16, 2021 Mar 18, 2021 Oric Pharmaceuticals, Inc. Director Sell 36.3 -66,202 -2.62% ✓ $1.9M
Mar 11, 2021 Mar 15, 2021 Oric Pharmaceuticals, Inc. Director Sell 22.5 -238,282 -8.62% ✓ $7.3M
Dec 8, 2020 Dec 8, 2020 ARS Pharmaceuticals, Inc. Director Buy 100.0 +1,190,477 221.01% ✗ $25M
Sep 25, 2020 Sep 29, 2020 Prelude Therapeutics Inc Director Buy 100.0 +1,236,800 597.74% ✗ $23.5M
Sep 25, 2020 Sep 29, 2020 CalciMedica, Inc. 10% Owner Buy 100.0 +562,500 100.00% ✗ $9M
Sep 21, 2020 Sep 23, 2020 89bio, Inc. Director Sell 16.3 -275,000 -6.87% ✗ $7.7M
May 21, 2020 May 26, 2020 scPharmaceuticals Inc. 10% Owner Buy 100.0 +1,387,283 40.68% ✗ $12M
Apr 24, 2020 Apr 28, 2020 Oric Pharmaceuticals, Inc. Director Buy 100.0 +281,250 100.00% ✗ $4.5M
Nov 11, 2019 Nov 13, 2019 89bio, Inc. Director Buy 100.0 +837,500 137.02% ✗ $13.4M
May 13, 2019 May 13, 2019 NextCure, Inc. Director Buy 100.0 +350,000 14.82% ✗ $5.3M
Feb 8, 2018 Feb 12, 2018 KALA BIO, Inc. 10% Owner Buy 75.0 +25,000 0.73% ✗ $323.3K
Feb 2, 2018 Feb 6, 2018 KALA BIO, Inc. 10% Owner Buy 85.0 +37,840 1.12% ✗ $557.4K
Jan 31, 2018 Feb 2, 2018 KALA BIO, Inc. 10% Owner Buy 100.0 +362,240 11.98% ✗ $5.4M
Jan 30, 2018 Jan 30, 2018 Adicet Bio, Inc. Director Buy 100.0 +533,333 12.41% ✗ $8M
Jan 26, 2018 Jan 30, 2018 KALA BIO, Inc. 10% Owner Buy 87.5 +72,760 2.47% ✗ $1.1M
Jan 12, 2018 Jan 24, 2018 KALA BIO, Inc. 10% Owner Buy 95.0 +257,285 9.55% ✗ $3.8M
Jan 10, 2018 Jan 12, 2018 KALA BIO, Inc. 10% Owner Buy 95.0 +240,484 9.81% ✗ $3.2M
Nov 21, 2017 Nov 21, 2017 scPharmaceuticals Inc. 10% Owner Buy 100.0 +833,333 32.34% ✗ $11.7M
Jul 25, 2017 Jul 27, 2017 KALA BIO, Inc. 10% Owner Buy 100.0 +319,333 15.53% ✗ $4.8M